STZ vs TPST · P/E 14, rev $9.14B vs $26.3M cap
Constellation Brands Inc Class A (STZ) versus Tempest Therapeutics Inc (TPST) — a side-by-side from cached financials, not a winner call.
Constellation Brands Inc Class A (STZ) is a beverages - brewers company listed on US.
Tempest Therapeutics Inc (TPST) is a biotechnology company listed on US.
Latest reported STZ revenue for 2026-02-28 was $9.14B. Net income was $1.69B. Revenue was up 322.3% from 2025-02-28 to 2026-02-28. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
TPST does not have a complete income-statement cache yet.
STZ currently screens at market cap $23.73B and trailing P/E 14.4. TPST currently screens at market cap $26.3M.
Not investment advice. Open the STZ and TPST stock pages for the full models.
Not investment advice.